Stories
Jubilant Pharmova Board Approves Rs 800 Crore NCD Issue
N
News18•12-10-2026, 23:15
Jubilant Pharmova Board Approves Rs 800 Crore NCD Issue
- •Jubilant Pharmova Ltd announced that its Board of Directors approved raising up to Rs 800 crore through non-convertible debentures on a private placement basis.
- •The plan includes issuing up to 80,000 fully paid-up NCDs with a face value of Rs 1,00,000 each in one or more tranches.
- •The debentures will have a tenure of up to five years and are proposed to be listed on the BSE.
- •The company will also seek shareholders approval via postal ballot to issue non-convertible debt securities up to an aggregate amount of Rs 2,500 crore.
Key Questions Answered
Jubilant Pharmova's board approved the issuance of non-convertible debentures aggregating up to Rs 800 crore on a private placement basis.
The company approved up to 80,000 NCDs with a face value of Rs 1,00,000 each, carrying a tenure of up to five years from the deemed date of allotment.
The debentures are proposed to be listed on the BSE.
